The brokerage has reduced its pharmacy target valuation from 25x to 22x, resulting in a lower SoTP by Rs 290 per share. "Keeping the hospital multiple intact (24x) and rolling over to FY26, our revised target price is Rs 7,300 (from Rs 7,500); we maintain ‘BUY," it said.
Shares of Apollo Hospitals Enterprise fell over 8 percent in intra-day trading today after the firm announced that it will raise ₹2,475 crore through private equity firm Advent International for its unit Apollo HealthCo. Investors expressed concern about the valuation assigned to Apollo 24/7.
Shares of Apollo Hospitals tumbled more than 8.30 per cent on Monday in a knee-jerk reaction to Rs 5738, with a total market capitalization less than Rs 85,000 crore.